Pruis MA - Search Results

1

Personalised selection of experimental treatment in patients with advanced solid cancer is feasible using whole-genome sequencing.

Pruis MA, Groenendijk FH, Badloe KS, van Puffelen A, Robbrecht D, Dinjens WNM, Sleijfer S, Dingemans AC, von der Thüsen JH, Roepman P, Lolkema MP. Pruis MA, et al. Br J Cancer. 2022 Sep;127(4):776-783. doi: 10.1038/s41416-022-01841-3. Epub 2022 May 23. Br J Cancer. 2022. PMID: 35606463 Free PMC article.

2

Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer.

Pruis MA, Geurts-Giele WRR, von der TJH, Meijssen IC, Dinjens WNM, Aerts JGJV, Dingemans AMC, Lolkema MP, Paats MS, Dubbink HJ. Pruis MA, et al. Lung Cancer. 2020 Feb;140:46-54. doi: 10.1016/j.lungcan.2019.11.010. Epub 2019 Nov 18. Lung Cancer. 2020. PMID: 31862577 Free article.

3

A Lung Cancer Patient with Dyspnea: Diagnostic Difficulties during the COVID-19 Pandemic.

Pruis MA, Hussain B, Bakker M, Hoek RAS, Miedema JR, Dingemans AC, Paats MS. Pruis MA, et al. Cancer Cell. 2020 Nov 9;38(5):611-612. doi: 10.1016/j.ccell.2020.10.005. Epub 2020 Oct 9. Cancer Cell. 2020. PMID: 33068525 Free PMC article. No abstract available.

4

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer.

Steendam CMJ, Veerman GDM, Pruis MA, Atmodimedjo P, Paats MS, van der Leest C, von der Thüsen JH, Yick DCY, Oomen-de Hoop E, Koolen SLW, Dinjens WNM, van Schaik RHN, Mathijssen RHJ, Aerts JGJV, Dubbink HJ, Dingemans AC. Steendam CMJ, et al. Among authors: pruis ma. Cancers (Basel). 2020 Oct 29;12(11):3179. doi: 10.3390/cancers12113179. Cancers (Basel). 2020. PMID: 33138052 Free PMC article.

5

MET immunochemistry: a reliable screening tool for MET exon 14 skipping mutations in non-small cell lung cancer?

Pruis MA, von der Thüsen JH, Dubbink HJ. Pruis MA, et al. Ann Transl Med. 2020 Nov;8(22):1538. doi: 10.21037/atm-20-3763. Ann Transl Med. 2020. PMID: 33313283 Free PMC article. No abstract available.

6

Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial.

de Rouw N, Boosman RJ, Burgers JA, Huitema ADR, Dingemans AC, Derijks HJ, Burger DM, Piet B, Hendriks LEL, Biesma B, Pruis MA, Dumoulin DW, Croes S, Mathijssen RHJ, van den Heuvel MM, Ter Heine R. de Rouw N, et al. Among authors: pruis ma. Cancer Chemother Pharmacol. 2023 Jan;91(1):33-42. doi: 10.1007/s00280-022-04489-1. Epub 2022 Nov 21. Cancer Chemother Pharmacol. 2023. PMID: 36413252 Free PMC article. Clinical Trial.

7

Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-Up.

Pruis MA, Veerman GDM, Hassing HC, Lanser DAC, Paats MS, van Schaik RHN, Mathijssen RHJ, Manintveld O, Dingemans AC. Pruis MA, et al. JACC CardioOncol. 2023 Jan 17;5(1):102-113. doi: 10.1016/j.jaccao.2022.09.006. eCollection 2023 Feb. JACC CardioOncol. 2023. PMID: 36875894 Free PMC article.

8

Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer.

de Leeuw SP, Pruis MA, Sikkema BJ, Mohseni M, Veerman GDM, Paats MS, Dumoulin DW, Smit EF, Schols AMWJ, Mathijssen RHJ, van Rossum EFC, Dingemans AC. de Leeuw SP, et al. Among authors: pruis ma. J Thorac Oncol. 2023 Aug;18(8):1017-1030. doi: 10.1016/j.jtho.2023.03.020. Epub 2023 Mar 29. J Thorac Oncol. 2023. PMID: 37001858

9

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer.

Pruis MA, Krebs MG, Plummer R, De Vos F, Angevin E, Prenen H, Forster MD, Clack G, Van der Aa A, Tjwa M, Jansen E, Perera T, Lolkema MP. Pruis MA, et al. Oncologist. 2023 Dec 11;28(12):e1248-e1258. doi: 10.1093/oncolo/oyad146. Oncologist. 2023. PMID: 37260332 Free PMC article. Clinical Trial.

10

A phase 1 open-label study to assess the relative bioavailability of TAK-931 tablets in reference to powder-in-capsule in patients with advanced solid tumors.

Steeghs N, Pruis M, van Herpen C, Lu V, Redman J, Zhou X. Steeghs N, et al. Invest New Drugs. 2023 Feb;41(1):53-59. doi: 10.1007/s10637-022-01318-3. Epub 2022 Nov 21. Invest New Drugs. 2023. PMID: 36409435 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page